Neurotransmitter reuptake transporter

Neurotransmitter reuptake transporters are specialized membrane proteins located primarily on presynaptic neurons. Their main role is to remove released neurotransmitters from the synaptic cleft by transporting them back into nerve terminals—a process known as "reuptake." This mechanism is essential for terminating signal transmission between neurons and recycling transmitter molecules for future use. These proteins belong mainly to solute carrier families such as SLC6 and SLC1; notable examples include serotonin transporter (SERT), dopamine transporter (DAT), norepinephrine transporter (NET), glutamate transporters, and GABA transporters. Pharmacologically modulating these targets has profound effects on brain chemistry—many antidepressants work by inhibiting monoamine reuptake while certain stimulants block dopamine/norepinephrine uptake. Dysfunction or dysregulation in these systems is implicated in a range of neuropsychiatric conditions including depression, anxiety disorders, substance abuse/addiction syndromes, epilepsy/seizures due to altered inhibitory/excitatory balance—and potentially neurodegenerative diseases. Because they directly regulate extracellular levels of key signaling molecules in the brain's communication network—and because many drugs act here—they are considered major therapeutic targets across psychiatry and neurology.

Other names

Neurotransmitter transporterReuptake transporterPlasma membrane neurotransmitter transporterSLC (solute carrier) family transporters (includes specific subtypes such as SERT, DAT, NET, GAT, etc.)

Drugs targeting these transporters typically act by inhibiting the reuptake function—blocking the ability of the transporter to move its substrate from the synaptic cleft back into the presynaptic neuron. This increases extracellular concentrations of specific neurotransmitters and prolongs their action at postsynaptic receptors. Some drugs can also reverse or alter normal directionality to increase release into the synapse.